(News Bulletin 247) – Invest Securities announces this morning that it is maintaining its ‘neutral’ advice on the Medesis share, with an unchanged price target of 3.3 euros.
While the Commercial Court of Montpellier condemned Medesis to pay 1.4 ME to Bpifrance, ‘Medesis decided to appeal this judgment after announcing its first intention to discuss with the Management of Bpifrance to identify a suitable repayment plan. ‘, reports the
‘ At this stage, we have identified 3 possible scenarios, the central scenario seeming to us the most likely if Medesis manages to demonstrate that the subsidies received (representing nearly half of the amount required by Bpifrance) and not repayable in theory, n ‘do not have to be reimbursed in the context of this dispute’, indicates the broker.
For its part, Medesis continues to make progress on its R&D programs for which some delays are to be anticipated in the short term, adds Invest.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
